Advertisement

Pankreastumoren

  • U. Graeven
  • H. P. Dienes
  • T. Becker
  • W. Schmiegel
Chapter

Zusammenfassung

Man unterscheidet benigne und maligne Pankreastumoren. Die benignen Formen bilden die Adenome und Zysten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zu Abschn. 64.1

  1. Gudjonsson B (1987) Cancer of the pancreas — 50 years of surgery. Cancer 60: 2284–2303PubMedCrossRefGoogle Scholar
  2. Klimstra DS, Heffess CS, Oertel JE, Rosai J (1992) Acinar cell carcinoma of the pancreas. A clinicopathologic of 28 cases. Am J Surg Pathol, 16: 815–837PubMedCrossRefGoogle Scholar
  3. Klöppel G (1984) Pancreatic, non-endocrine tumors. In: Klöppel G, Heitz PH (eds) Pancreatic pathology. Churchill Livingstone, New York, pp 79–113Google Scholar
  4. Lewin K (1987) Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11 (Suppl): 71–86PubMedCrossRefGoogle Scholar
  5. Nojima T, Nakamura F, Ishikura M, Inoue K, Nagashima K, Kato H (1993) Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells. Int J Pancreatol 14: 275–281PubMedGoogle Scholar
  6. Solcia E, Capella C, Klöppel G (1997) Tumors of the Pancreas Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  7. Stolte M, Weiss W, Volkholz H, Rösch W (1982) A special form of segmental pancreatitis: groove pancreatitis. Hepatogastroenterology 29: 198–208PubMedGoogle Scholar
  8. Tracey KJ, O’Brien MJ, Williams LF et al. (1984) Signet ring carcinoma of the pancreas, a rare variant with very high CEA values. Immunohistologic comparsion with adenocarcinoma. Dig Dis Sci 29: 573–576PubMedCrossRefGoogle Scholar
  9. Warshaw AL, Campton CC, Lewandrowsky K, Cardenosa G, Mueller PR (1990) Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 212: 432–445PubMedCrossRefGoogle Scholar
  10. Yamada M, Kozuka S, Yamao K, Nakazawa S, Naitoh Y, Tsukamoto Y (1985) Mucin-producing tumor of the pancreas. Cancer 56: 1434–1445CrossRefGoogle Scholar

Zu Abschn. 64.2-64.6

  1. Auerbach M, Wampler GL, Lokich J et al. (1997) Treated pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study. Ann Oncol 8: 439–444PubMedCrossRefGoogle Scholar
  2. Bakkevold KE, Pattersen A, Ames JB et al. (1990) Tamoxifen therapy in unresectable adenocarinoma of the pancreas and the papilla of Vater. Br J Surg 77: 725–730PubMedCrossRefGoogle Scholar
  3. Bakkevold KE, Arnejo B, Kambestad B (1992) Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. Scand J Gastroenterol 27: 317–325PubMedCrossRefGoogle Scholar
  4. Bakkevold KE, Arnesjo B, Dahl O et al. (1993) Adjuvant combination chemotherapy (DMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective randomized multcentre study. Eur J Cancer 29: 698–703CrossRefGoogle Scholar
  5. Barthelmy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L (1995) Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123: 188–191Google Scholar
  6. Burris HA, Moore MJ, Andersen J et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403–2413PubMedGoogle Scholar
  7. Evans DB, Abbruzzese JL, Rich TA (1997) Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology, vol I. Lippincott-Raven, Philadelphia, pp 1054–1087Google Scholar
  8. Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer: a metaanalysis. JAMA 273: 1605–1609PubMedCrossRefGoogle Scholar
  9. Faigel DO, Ginsberg GG, Bentz JS et al. (1997) Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol 15: 1439–1443PubMedGoogle Scholar
  10. Fernandes del Castillo C, Rattner DW, Warshaw AL (1995) Further experience with laparoscopy and peritoneal cytotology in the staging of pancreatic cancer. Br J Surg 82: 1127–1129CrossRefGoogle Scholar
  11. Fernandez E, La Vecchia C, Porta M et al. (1995) Pancreatitis and the risk of pancreatic cancer. Pancreas 11: 185–189PubMedCrossRefGoogle Scholar
  12. Fuhmann GM, Charnsangavej C, Abbruzzese JL et al. (1994) Thin-section contrast enhanced computed tomography accurately predicts resectability of malignant pancreatic neoplasms. Am J Surg 167: 104–113CrossRefGoogle Scholar
  13. Gansauge F, Gansauge S, Parker N et al. (1996) CAM 17.1 — A new diagnostic marker in pancreatic cancer. Br J Cancer 74: 1997–2002PubMedCrossRefGoogle Scholar
  14. Gastrointestinal Tumor Study Group (1988) Treatment of locally unresectable carcinoma of the pancreas: comparison of combine D-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80: 751–755CrossRefGoogle Scholar
  15. Glimelius B, Hoffman K, Sjödén P-O et al. (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7: 593–600PubMedCrossRefGoogle Scholar
  16. Gullo L, Pezzilli R, Morselli-Labate AM (1994) Diabetes and the risk of pancreatic cancer. N Engl J Med 331: 81–84PubMedCrossRefGoogle Scholar
  17. Hahn SA, Kern SE, Schmiegel W (1994) Neue molekularbiologische Erkenntnisse aus der Pankreaskarzinom-Forschung. Dtsch Ärzteblatt 49: B2706–B2712Google Scholar
  18. Ho CL, Dehdashti F, Griffeth LK, Buse PE, Balfe DM, Siegel BA (1996) FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr 20: 363–369PubMedCrossRefGoogle Scholar
  19. Hoffmann JP, Weese JL, Lolin LJ et al. (1995) Preoperative chemoradiation for patients with resectable pancreatic adenocarcinoma: an Eastern Cooperative Oncology Group (ECOG) phase I study (abstract). Proc Am Soc Clin Oncol 14: 201Google Scholar
  20. Klaassen DJ, MacIntyre JM, Catton GE et al. (1985) Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil: an Eastern Cooperative Oncology Group study. J Clin Oncol 3: 373–378PubMedGoogle Scholar
  21. Mallinson CN, Rake MO, Cocking JB (1980) Chemotherapy in pancreas cancer. Br Med J 281: 1589–1591PubMedCrossRefGoogle Scholar
  22. Marisa T, Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75: 171–190CrossRefGoogle Scholar
  23. Moertel CG, Frytak S, Hahn RG et al. (1981) Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6.000 rads) radiation alone, moderate dose radiation (4.000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48: 1705–1710PubMedCrossRefGoogle Scholar
  24. Niederau C, Grendell JH (1992) Diagnosis of pancreatic carcinoma: Imaging techniques and tumor markers. Pancreas 7: 66–86PubMedCrossRefGoogle Scholar
  25. Palmer KR, Kerr M, Knowels G et al. (1994) Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 81: 882–885PubMedCrossRefGoogle Scholar
  26. Permert J, Ihse I, Jorfeldt L et al. (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159: 101–107PubMedGoogle Scholar
  27. Rösch T, Braig Ch, Gain T et al. (1992) Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography: Comparision with conventional sonography, computed tomography, and angiography. Gastroenterology 102: 188–199PubMedGoogle Scholar
  28. Rosenberg L, Barkun A, Denis MH et al. (1995) Low dose Octreotide and Tamoxifen in the treatment of adenocarcinoma of the pancreas. Cancer 75: 23–28PubMedCrossRefGoogle Scholar
  29. Schmiegel W, Schmielau J, Henne-Bruns D et al. (1997) Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapie of pancreatic cancer. Proc Natl Acad Sci 94: 12622–12626PubMedCrossRefGoogle Scholar
  30. Staley CA, Lee JE, Cleary KA et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171: 118–125PubMedCrossRefGoogle Scholar
  31. Taylor OM, Benson IA, McMahon MJ (1993) Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma: the Yorkshire Gastrointestinal Tumor Group. Br J Surg 80: 384–386PubMedCrossRefGoogle Scholar
  32. Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161: 26–29PubMedCrossRefGoogle Scholar
  33. Wilentz RE, Chung CH, Sturm PDJ et al. (1998) K-ras Mutations in the duodenal fluid of patients with pancreatic carcinoma. Am Cancer Society 82: 96–103Google Scholar
  34. Wong A, Chan A (1993) Survival benefit of tamoxifen therapy in adenocarinoma of the pancreas. A case control study. Cancer 71: 2200–2203Google Scholar
  35. World Cancer Research Fund, American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, WashingtonGoogle Scholar
  36. Yeo CJ, Cameron JL, Lillemore KD et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221: 721–733PubMedCrossRefGoogle Scholar

Zu Abschn. 64.7

  1. Alterna JH, Reinders ME, van Gulik TM, van Leeuwen DJ, de Wit LT, Verbeek PCM, Gouma DJ (1994) Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg 81: 1642–1646CrossRefGoogle Scholar
  2. Baer HU, Wagner M, Sadowski C, Büchler MW (1996) Pankreas-Karzinom: Chirurgische Therapie. Ther Umsch 53: 394–400PubMedGoogle Scholar
  3. Bakkevold KE, Kambestad B (1993) Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas an papilla of Vater — the prognostic factors influencing the long-term results. A prospective multicentre study. Eur J Surg Oncol 19: 147–161PubMedGoogle Scholar
  4. Beger HG, Büchler MW, Friess H (1994) Chirurgische Ergebnisse und Indikation zu adjuvanten Maßnahmen beim Pankreascarcinom. Chirurg 65: 246–252PubMedGoogle Scholar
  5. Beger HG, Birk D, Bodner E, Fritsch A, Gall FP, Trede M (1995) Ist die histologische Sicherung des Pankreaskarzinoms Voraussetzung für die Pankreasresektion? Langenbecks Arch Chir 380: 62–66PubMedGoogle Scholar
  6. Bodner J, Bodner E (1998) Präoperatives Gallengangstenting. Chir Gastroenterol 14: 37–41CrossRefGoogle Scholar
  7. Bühler L, Niederer HM, Morel PH (1998) Pankreaskarzinom: Welche Faktoren bestimmen die Resektabilität? Chir Gastroenterol 14: 29–31CrossRefGoogle Scholar
  8. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman JRN (1993) One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217: 430–438PubMedCrossRefGoogle Scholar
  9. Fortner JG (1973) Regional resection of cancer of the pancreas: a new surgical approach. Surgery 73: 307–320PubMedGoogle Scholar
  10. Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60: 2284–2303PubMedCrossRefGoogle Scholar
  11. Henne-Bruns D, Vogel I, Lüttges J, Klöppel G, Kremer B (1998) Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy. Hepatogastroenterol 45: 855–866Google Scholar
  12. Ihse I, Andersson R, Axelson J, Hansson L (1998) Kombinationstherapie in der Onkologie (multimodale Behandlung) bei Pankreastumoren. Chirurg 69: 366–370PubMedCrossRefGoogle Scholar
  13. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R (1995 a) Multivariate Analyse von Prognosefaktoren nach Resektion duktaler Pankreaskarzinome. Langenbecks Arch Chir 380: 133–138PubMedGoogle Scholar
  14. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R (1995 b) Surgery for exocrine pancreatic cancer — Who are the 5-and 10-year survivors? Oncology 52: 353–359PubMedCrossRefGoogle Scholar
  15. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R (1996) Extended resections of ductal pancreatic cancer — Impact on operative risk and prognosis. Oncology 53: 47–53PubMedCrossRefGoogle Scholar
  16. Leitlinien der Dt. Krebsgesellschaft für Pankreaskarzinom (1997) Forum 12: 26–31Google Scholar
  17. Lillemoe KD, Barnes SA (1995) Surgical palliation of unresectable pancreatic carcinoma. Surg Clin North Am 75: 953–968PubMedGoogle Scholar
  18. Pitt HA, Gomes AS, Lois JF (1985) Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 201: 545–552PubMedCrossRefGoogle Scholar
  19. Roder JD, Stein JH, Hüttland W, Siewert JR (1992) Pyloruspreserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Surgery 79: 152–155Google Scholar
  20. Sindelar WF (1989) Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 124: 127–132PubMedCrossRefGoogle Scholar
  21. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile-duct obstruction. Lancet 344: 1655–1659PubMedCrossRefGoogle Scholar
  22. Takahashi S, Ogata Y, Tsuzuki T (1994) Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 81: 1190–1193PubMedCrossRefGoogle Scholar
  23. Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. Ann Surg 211: 447–458PubMedCrossRefGoogle Scholar
  24. Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161: 26–30PubMedCrossRefGoogle Scholar
  25. Warshaw AL, del Castillo CF (1992) Pancreatic carcinoma. N Engl J Med 326: 455–465PubMedCrossRefGoogle Scholar

Ergänzung im Druck

  1. Eine aktuelle Zusammenfassung von Diagnose und Therapie des Pankreskarzinoms findet sich im folgenden ArtikelGoogle Scholar
  2. DiMagno G, Reber HA, Tempero MA (1999) AGA Technical Review on the epidemiology diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 117: 1464–1484PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • U. Graeven
  • H. P. Dienes
  • T. Becker
  • W. Schmiegel

There are no affiliations available

Personalised recommendations